The highly reactive [4,4′-bi(1,3-dioxolane)]-2,2′-dione (BDC), also being referred to as erythritol dicarbonate and butadiene dicarbonate, enables the facile isocyanate-free tailoring and melt-processing of bio-based polyhydroxyurethane (PHU) materials. Both the direct carbonation of erythritol and the chemical fixation of CO2 with 2,2′-bioxirane, obtained by epoxidation of bioethanol-derived butadiene, afford high purity BDC in high yields. According to the FTIR spectroscopic model study BDC reacts with primary alkylamines at room temperature even in the absence of catalysts. High BDC reactivity is essential for producing high molar mass linear PHU thermoplastics via melt-phase polyaddtition with aliphatic diamines. Opposite to conventional isoycanate-mediated polyurethane syntheses erythritol units are incorporated into the polyurethane backbone without requiring the use of protective groups. As a function of the diamine structures and copolymer compositions the PHU properties vary from hard to soft and elastomeric. Typically isophorone diamine (IPDA) and trimethylhexamethylenediamine (TMHMDA) serve as building blocks for hard segments whereas highly flexible diamines such dimer fatty acid-derived diamidoamines render PHU soft and elastomeric. This study elucidates how copolymer composition and reaction parameters such as temperature, catalyst, and stabilizer addition influences PHU molar masses as well as mechanical and thermal properties. For the first time, owing to extraodinary BDC reactivity, melt-phase BDC polyaddition with diamines is competitive with conventional reactive processing of polyurethane thermoplastics using isocyanates. Moreover this versatile isocyanate-free synthetic route offers a great variety of options for fabricating unconventional bio-based PHUs and carbohydrate urethanes unparalleled by conventional polyurethanes.
Glycerol serves as the exclusive bio feedstock for the preparation of high purity sorbitol tricarbonate (STC) as new intermediate for poly(carbohydrate−urethane) thermosets and 100% bio-based non-isocyanate polyhydroxyurethane (NIPU) coatings. In this process, glycerol-based acrolein is dimerized, carbonated, and oxidized, thus producing the highly reactive diepoxy functional ethylene carbonate (DOC), which by facile chemical CO 2 fixation yields high purity STC. Opposite to most state-of-the-art multifunctional five-membered cyclic carbonates and regardless of the feedstock used for its manufacture, STC enables amine curing at ambient temperature even in the absence of catalysts. According to FT-IR and NMR spectroscopic analyses of the amine/carbonate reaction kinetics, the internal cyclic carbonate group is 3 times more reactive with respect to the two terminal carbonate groups. This is attributed to the electronwithdrawing effect of terminal cyclic carbonates. Curing STC with a blend of bio-based flexible and rigid diamines such as dimer fatty acid-based diamine (Priamine 1074) and isophorone diamine affords poly(carbohydrate−urethane) thermosets and NIPU coatings exhibiting substantially improved thermal and mechanical properties.
Common sugar alcohols used as artificial sweeteners and components of polymer networks represent low molecular weight polyhydroxymethylenes (PHMs) with the general formula [CH(OH)]nH2 but very low degree of polymerization (n = 2–6). Herein high molecular weight PHM (n >> 100) unparalleled in nature is tailored for 3D printing and medical applications by free radical polymerization of 1,3‐dioxol‐2‐one vinylene carbonate to produce polyvinylene carbonate (PVCA) which yields PHM by hydrolysis. Furthermore, PVCA is solution processable and enables PHM functionalization, membrane formation, and extrusion‐based 3D printing. Opposite to cellulose, amorphous PHM is plasticized by water and is readily functionalized via PVCA aminolysis/hydrolysis to produce polyhydroxymethylene urethane (PHMU), enable PHM crosslinking and coupling of PHM with amine‐functional components like gelatin. After hydrolysis/aminolysis the original PVCA shapes are retained. PVCA solution casting yields PVCA and PHM which exhibits uniform and hierarchic pore architectures. Asymmetric membranes, hydrogels, PHM/collagen blends, and electrospun nonwovens of PVCA, PHM, and PHMU are readily tailored for medical applications. 3D printing of PVCA dispersions containing hydroxyapatite affords porous PVCA, PHMU, and PHM scaffolds useful in regenerative medicine. PHM and functionalized PHMs as carbohydrate‐inspired multifunctional materials indicate in vitro biocompatibility and hold great promise for applications in medicine and health care.
Previous mouse studies have shown the increased presence of platelets in the myocardium during early stages of myocarditis and their selective detection by MRI. Here, we aimed to depict early myocarditis using molecular contrast-enhanced ultrasound of activated platelets, and to evaluate the impact of a P2Y12 receptor platelet inhibition. Experimental autoimmune myocarditis was induced in BALB/c mice by subcutaneous injection of porcine cardiac myosin and complete Freund adjuvant (CFA). Activated platelets were targeted with microbubbles (MB) coupled to a single-chain antibody that binds to the “ligand-induced binding sites” of the GPIIb/IIIa-receptor (=LIBS-MB). Alongside myocarditis induction, a group of mice received a daily dose of 100 g prasugrel for 1 month. Mice injected with myosin and CFA had a significantly deteriorated ejection fraction and histological inflammation on day 28 compared to mice only injected with myosin. Platelets infiltrated the myocardium before reduction in ejection fraction could be detected by echocardiography. No selective binding of the LIBS-MB contrast agent could be detected by either ultrasound or histology. Prasugrel therapy preserved ejection fraction and significantly reduced platelet aggregates in the myocardium compared to mice without prasugrel therapy. Therefore, P2Y12 inhibition could be a promising early therapeutic target in myocarditis, requiring further investigation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.